Compare Dominion Energy Inc (D) vs Novavax Inc (NVAX) Price & Performance

Dominion Energy (D) trades at $61.69, up 0.25% with a bearish technical signal despite recent earnings beats. The company shows strong fundamental improvement with revenue growing to $16.51B in 2025 and net income margin expanding to 18.16%. Analyst consensus is mixed with 36% buy ratings but a $71.56 price target suggests 16% upside potential. Recent news highlights the pending merger with NextEra Energy and ongoing infrastructure investments.

Dominion Energy presents a compelling value opportunity with reasonable valuation multiples (P/E 21.37, P/S 2.96) and consistent earnings outperformance. However, the stock faces headwinds from high debt levels (debt-to-asset ratio 43.49%) and regulatory uncertainty surrounding the proposed merger. The dividend yield of approximately 4.3% provides income support while investors await merger resolution and continued operational execution.

Novavax (NVAX) trades at $12.41, up 10.61% today, with strong technical momentum and bullish moving average signals. The company shows mixed fundamentals with a low P/E of 3.14 and EV/EBITDA of 1.72, but negative net income margin of -59.87% and negative shareholder equity. Recent earnings beats and FDA approvals for updated COVID-19 vaccines provide near-term catalysts.

Investment outlook remains speculative with significant execution risks despite analyst optimism (74% buy ratings). The company's pivot to Matrix-M adjuvant licensing and partnership model offers growth potential, but negative cash flow and high debt levels pose substantial financial risk. Stock appears undervalued on some metrics but requires careful risk management.